跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 329 条关于
“entX”
全部
329
临床试验
181
药物
116
机构
8
资讯
24
去年
Entera Bio to Present Phase 2 Osteoporosis Data and Next-Generation Oral Peptide Programs at September 2025 Conferences
去年
Entera Bio Announces Positive Updates on Oral Peptide Programs and Q3 2024 Financial Results
10个月前
UK Launches £18.8 Million Initiative to Transform Nuclear Waste into Precision Cancer Therapies
上个月
Entera Bio Secures $275 Million to Fund Phase III Trial of First Oral Osteoanabolic Tablet for Osteoporosis
去年
OPKO Health and Entera Bio Collaborate to Develop First Oral GLP-1/Glucagon Dual Agonist for Obesity Treatment
2年前
BioNTech Highlights Oncology Pipeline Progress and Strategic Investments in Q4 2023 Earnings Call
去年
Edgewise Therapeutics Announces 2025 Priorities Following Positive Phase 2 Results
2年前
Neuraptive's NTX-001 Receives FDA Breakthrough Therapy Designation for Peripheral Nerve Injury
去年
Novartis Unveils NVP-FVP954: A Novel IV Antimalarial for Severe Malaria
2个月前
Epigenetic Therapy NTX-301 Activates Hippo Pathway to Overcome Treatment-Resistant AML
第 1 页,共 3 页
上一页
下一页